Distribuzione geografica
Continente #
NA - Nord America 3170
EU - Europa 364
AF - Africa 169
AS - Asia 59
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 3777
Nazione #
US - Stati Uniti d'America 3145
NG - Nigeria 169
FR - Francia 88
IT - Italia 86
NL - Olanda 49
GB - Regno Unito 38
DE - Germania 35
CA - Canada 23
BE - Belgio 20
TR - Turchia 15
IL - Israele 12
FI - Finlandia 8
RO - Romania 7
RU - Federazione Russa 7
AT - Austria 5
BR - Brasile 5
ES - Italia 5
IN - India 5
IQ - Iraq 5
IR - Iran 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
CN - Cina 3
GR - Grecia 3
JP - Giappone 3
NO - Norvegia 3
UA - Ucraina 3
AU - Australia 2
BD - Bangladesh 2
EU - Europa 2
KR - Corea 2
PL - Polonia 2
SA - Arabia Saudita 2
SG - Singapore 2
CH - Svizzera 1
CU - Cuba 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SE - Svezia 1
Totale 3777
Città #
Chandler 886
Wilmington 833
San Mateo 316
Ann Arbor 266
Benin City 169
Lawrence 155
Princeton 155
Leawood 141
Paris 83
Fairfield 72
Woodbridge 69
Boardman 56
Amsterdam 47
Milan 35
London 33
Seattle 27
Brussels 20
San Diego 20
Toronto 20
Abbiategrasso 17
Redwood City 17
Norwalk 15
Kocaeli 14
Hanover 9
Helsinki 8
Clearwater 6
Des Moines 5
Houston 5
Redmond 5
Andover 4
Ashburn 4
Baghdad 4
Gunzenhausen 4
Madrid 4
Sacramento 4
Cambridge 3
Desio 3
Monmouth Junction 3
Novokuznetsk 3
Ottawa 3
São Paulo 3
Alexandria 2
Beijing 2
Berlin 2
Frankfurt am Main 2
Kolkata 2
Los Angeles 2
New York 2
Parkville 2
Reghin 2
Torino 2
Aachen 1
At Tuwal 1
Athens 1
Augusta 1
Bagneux 1
Bitola 1
Bollebygd 1
Bucharest 1
Bussolengo 1
Cagayan de Oro 1
Canberra 1
Chicago 1
Chisinau 1
Cuajimalpa 1
Dallas 1
Eden Prairie 1
Erbil 1
Fremont 1
Hangzhou 1
Irving 1
Kashan 1
Kemerovo 1
Kuala Lumpur 1
La Canada Flintridge 1
Manassas 1
Manchester 1
Media 1
Mumbai 1
Pakpattan 1
Raleigh 1
Riyadh 1
Rochester 1
Saint Paul 1
San Francisco 1
Saratov 1
Schiffweiler 1
Singapore 1
Spring 1
Targu 1
Tokyo 1
Udine 1
Ulaanbaatar 1
Valbonne 1
Vienna 1
Vitória 1
Washington 1
Wigan 1
Totale 3613
Nome #
The X chromosome and immune associated genes 46
Lights and Shadows on Fibrates as Second-Line Therapy of Primary Biliary Cholangitis 46
Definition of human autoimmunity - autoantibodies versus autoimmune disease 45
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 44
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 41
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 41
High mortality in COVID-19 patients with mild respiratory disease 40
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 40
Autophagy: highlighting a novel player in the autoimmunity scenario 38
Liver Injury Induced by Immune Checkpoint Inhibitors: An Affordable Risk of Cancer Therapy? 37
Interferon α and its contribution to autoimmunity 36
The consequences of apoptosis in autoimmunity 36
Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis 36
Making sense of Autoantibodies in Cholestatic Liver Diseases 35
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 35
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 35
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 35
HLA Class II antigens associated with lupus nephritis in Italian SLE patients 34
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 34
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario 34
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 34
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 34
Apotopes and the biliary specificity of primary biliary cirrhosis 33
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis 33
Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes 33
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 33
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 33
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy) 33
The risk of Liver Cancer in Autoimmune Liver Diseases 32
Genetics and epigenetics of primary biliary cirrhosis 32
Is autoimmunity a matter of sex? 32
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 32
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 32
Hepatotoxicity of immune check point inhibitors: Approach and management 32
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis 32
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis 31
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals 31
Benign Liver Tumors 31
Evolving trends in female to male incidence and male mortality of primary biliary cholangitis 31
Autoimmunity and Turner's syndrome 31
Role of liver biopsy in hepatocellular carcinoma 31
COVID-19 and liver cancer clinical trials: not everything is lost 30
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature 30
Geoepidemiology, Genetic and Environmental Risk Factors for PBC 30
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 30
Identifying medical professionals at risk for in-hospital COVID-19 infection: a snapshot during a "tsunami" highlighting unexpected risks 30
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 29
Hepatitis C virus eradication with DAA and liver cancer recurrence: is the best the enemy of the good? 29
Changes in the Epidemiology of Primary Biliary Cholangitis 29
Advances in pharmacotherapy for primary biliary cirrhosis 29
Apotopes and innate immune system: Novel players in the primary biliary cirrhosis scenario 29
The immunological potential of galectin-1 and 3 29
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis 29
Prevalence and clinical significance of intrahepatic cholangiocellular carcinoma with radiological enhancement pattern mimicking hepatocellular carcinoma 29
Mediterranean diet and NAFLD: what we know and questions that still need to be answered. 28
Impact of RAS mutations on the immune infiltrate of colorectal liver metastases patients: A preliminary study 28
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 28
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study 28
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 28
Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment 28
Primary biliary cholangitis: a comprehensive overview. 27
Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases 27
Postsustained Virological Response Management in Hepatitis C Patients 27
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference 27
Common Variable Immunodeficiency and Liver Involvement 27
Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase 27
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 27
Levels of Alkaline Phosphatase and Bilirubin are Surrogate Endpoints of Outcomes of Patients with Primary Biliary Cirrhosis - an International Follow-up Study 27
Interpreting serological tests in diagnosing autoimmune liver diseases 26
Towards common denominators in Primary Biliary Cirrhosis: the role of IL-12 26
Y chromosome loss in male patients with primary biliary cirrhosis 26
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells 26
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review 26
Is there a real survival benefit of surveillance for HCC in cirrhotic patients? 26
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis 26
Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infections 26
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 26
Innate Immunity and Primary Biliary Cirrhosis 26
Etiopathogenesis of primary biliary cirrhosis 26
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis 26
Safety of vedolizumab in liver transplant recipients: A systematic review 26
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine 25
The impact of antiviral therapy on hepatocellular carcinoma epidemiology 25
DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis 25
Primary biliary cirrhosis and autoimmune cholangitis 25
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy 25
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis 25
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 25
Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infections 24
The X-Factor in Primary Biliary Cirrhosis: Monosomy X and Xenobiotics 24
Comparative analysis of portal cell infiltrates in AMA positive versus AMA negative PBC 24
Modulation of CD4(+) T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis 24
Immunology of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis 24
Primary biliary cholangitis 24
The epigenetics of PBC: The link between genetic susceptibility and environment 24
Geoepidemiology, gender and autoimmune disease 23
Letter to the Editor: might denosumab fit in PBC treatment? 23
Coronary flow reserve is an innovative tool for the early detection of cardiovascular dysfunction in primary biliary cholangitis patients. 23
Primary biliary cirrhosis is associated with altered hepatic microRNA expression 23
Human β-Defensin 2 in Primary Sclerosing Cholangitis. 23
Totale 3006
Categoria #
all - tutte 20062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20062

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0000 00 00 00013
2020/20211536 24111111 9517 21294 2991795164
2021/2022853 311014182 711 22114 959520270
2022/20231515 348133244318 238217 170 0000
Totale 3917